Pathway Genomics is a clinical diagnostic and mobile healthcare technology company providing services worldwide.
Our genetic testing specialties include hereditary cancer, pharmacogenomic, and general health and wellness testing. Pathway Genomics strives to develop new and innovative testing and products, including a first-of-its-kind mobile health application in partnership with IBM Watson. Integrating genetic results with published data, this app will offer users personalized, immediate, and actionable hea
lth information. Located in San Diego, California, Pathway Genomics owns and operates an on-site genetic testing laboratory that is accredited by the College of American Pathologists (CAP), accredited in accordance with the U.S. Health and Human Services’ Clinical Laboratory Improvement Amendments (CLIA) of 1988, and licensed by the state of California. Since its founding in 2008, Pathway Genomics has become known for its dedication to innovation – making it a leader in the commercial healthcare industry. Focusing on providing users with the most validated and personalized healthcare information delivered to any device, the company’s program with IBM Watson is the first of its kind to merge artificial intelligence and deep learning with precision medicine, applicable to both consumers and providers. Based in San Diego, the company’s CLIA and CAP accredited clinical laboratory provides physicians and their patients in more than 40 different countries with actionable and accurate precision healthcare information to improve, or maintain, health and wellness. Pathway Genomics’ testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response for specific medications including those used in pain management and mental health. For more about Pathway Genomics, visit www.pathway.com.
